NCT05942105

Brief Summary

Breast conservative surgery (BCS) is nowadays the standard of care for patients affected by early breast lesions. Screening programmes led to an increase of non-palpable breast lesion detection rates. These patients are often eligible for BCS and an accurate preoperative localization technique for the detection of the lesion is required to guarantee a safe surgical excision. The primary goal of BCS is to obtain a complete resection of the tumor with disease-free surgical margins. The presence of tumor on surgical margins on postoperative histological examination of the specimen increases the risk of local recurrence and it requires a surgical re-excision. For all these reasons different techniques for localization of non-palpable breast lesions have been developed over time. Since '70s the wire guided localization (WGL) technique has represented the gold standard; however it has several limitations such as wire migration or fracture and patient referred discomfort related to wire placement. Over time, other techniques have been proposed, such as the radioguided occult lesion localization (ROLL), radioactive and magnetic seeds, carbon dye and ultrasound-guided preoperative localization. Currently there are several studies of comparison between the WGL and the more modern techniques. All of these data claim the effectiveness of the new "wire-free" methodics ensuring a safe surgical resection with tumor-free margins and, in some cases, a better aesthetic result. Studies of comparison between the modern techniques are limited. There is no scientific evidence of the superiority of a technique over the other. A multicentric Italian survey demonstrated that the most used localization techniques nowadays are the WGL, ROLL, the magnetic seed and the carbon dye. The aim of this retrospective study is to compare these techniques to assess their efficacy in the localization of non-palpable breast lesions.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,064

participants targeted

Target at P75+ for all trials

Timeline
26mo left

Started May 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
May 2023Sep 2028

Study Start

First participant enrolled

May 31, 2023

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

June 27, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 12, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
3.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2028

Expected
Last Updated

September 2, 2025

Status Verified

May 1, 2025

Enrollment Period

1.8 years

First QC Date

June 27, 2023

Last Update Submit

August 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Free-surgical margins

    Number of surgical procedures in which surgical margins are disease-free ("no ink on tumor" for invasive cancer and margin of 2 mm for in situ-carcinoma)

    6 months

Secondary Outcomes (6)

  • Excess breast resection

    6 months

  • Surgery time

    6 months

  • Hospitalization days

    6 months

  • Complications

    6 months

  • Reintervention

    6 months

  • +1 more secondary outcomes

Study Arms (4)

ROLL technique

Radioguided occult lesion localization

Procedure: Breast conservative surgery

MAGNETIC SEED

Magnetic seed localization

Procedure: Breast conservative surgery

WGL technique

Wire guided localization for non-palpable breast lesions

Procedure: Breast conservative surgery

CARBON

Carbon dye localization for non-palpable breast lesions

Procedure: Breast conservative surgery

Interventions

Breast conservative surgery after non-palpable lesion localization

CARBONMAGNETIC SEEDROLL techniqueWGL technique

Eligibility Criteria

Age18 Years - 85 Years
Sexfemale
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Breast cancer patients with non-palpable breast lesion candidated for conservative surgery

You may qualify if:

  • Female sex;
  • Patients who underwent breast conservative surgery for non-palpable occult breast lesions;
  • Intraoperative localization of breast lesion with WGL, ROLL, magnetic seed, carbon dye;
  • Preoperative diagnosis on histology or cytology of borderline lesion (B3 or C3) or malignant lesion (B4-B5 or C4-C5).

You may not qualify if:

  • Diagnosis of benign breast lesion, both on preoperative needle breast biopsy (B2) or on fine needle breast aspiration (C2);
  • Clinically palpable breast lesion;
  • Localization of a non-palpable lesion through two or more different techniques;
  • Breast tumor localization with clip in patients who underwent neoadjuvant chemotherapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituti Clinici Scientifici Maugeri SpA

Pavia, Lombardy, 27100, Italy

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 27, 2023

First Posted

July 12, 2023

Study Start

May 31, 2023

Primary Completion

March 30, 2025

Study Completion (Estimated)

September 30, 2028

Last Updated

September 2, 2025

Record last verified: 2025-05

Locations